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Item 12 of the provisional agenda 
Follow-up to the recommendations and decisions 
of the Sixth Review Conference and the question of 
future review of the Convention 
  Review and update of the Confidence-Building Measures 
  Submitted by Germany, Norway and Switzerland 
 I. Introduction 
 A. Why is a CBM update necessary? 
1. Over now more than twenty years, the annual number of States Parties submitting 
Confidence Building Measures (CBMs) has been somewhere between 30 at its lowest 
(1987) and 72 at its highest (2010). Annual CBM submissions are thus made on average by 
less than 40 percent of the States Parties to the BWC. This relative lack of participation in 
the CBM process is particularly unfortunate as the mechanism will only command limited 
transparency until more States Parties honour their commitments and submit declarations. 
Ignoring the mechanism weakens the concept of CBMs and may ultimately reduce, rather 
than build, confidence among States. The relative lack of participation in the CBM 
mechanism is compounded by inconsistent submissions, where states submit returns in 
some years but not in others, as well as by incomplete submissions, where only some of the 
seven forms are submitted. For these reasons the Final Document of the Sixth Review 
Conference states "the need for enhancing participation of States Parties in the confidence-
building measures (CBM) process" and "the issue merits further and comprehensive 
attention at the Seventh Review Conference"1. 
2. The CBMs were developed and agreed in 1986/1987 and 1991. They have not been 
modified in 21 years. In addition, some of the modalities agreed need clarification for better 
understanding. Some CBM forms contain references to official documents of international 
organizations that are outdated and require update. Furthermore, some information 
requested under the CBMs is now available on the internet and may therefore no longer 
require a declaration under the CBM forms. Finally, the CBM process can be streamlined 
  
 1 BWC/CONF.VI/6, Part III, paragraphs 8 and 9. 
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2  
by making use of electronic means that were not available in the past. But, this is a final 
step that may take place after agreement is achieved on proposed changes of substance.  
 B. Preparing proposals for CBM updates for adoption at the Seventh 
Review Conference 
3. The Governments of Switzerland, Norway and Germany together with the Geneva 
Forum in collaboration with the BIOS Centre of the London School of Economics 
organised three workshops in 2009 and 2010 to discuss the way forward for preparing the 
CBM discussion for the Seventh Review Conference. The workshops brought together a 
range of governmental and non-governmental experts to address key questions how to 
improve the CBM forms and the CBM process for increasing participation in the annual 
exchange. Discussion continued on an e-mail platform to which more than 70 experts from 
a wide range of States Parties, including from civil society, subscribed. The results of the 
workshops and the ongoing discussion were presented in the margins of the 2010 Meeting 
of Experts and Meeting of States Parties in Geneva. 
4. The process enabled a deeper reflection and provided further proposals that go 
beyond the suggested changes in the attached annex.  Such proposals would modify the 
CBM system more fundamentally in a way that would require further in depth attention, for 
instance in a future intersessional process. For this reason, these additional proposals are 
not included in the proposed changes here. Our immediate objective for the Review 
Conference is to reach agreement on streamlining the existing CBMs in order to increase 
the number of annual submissions and improve their quality. 
5. At workshops in preparation for the Seventh Review Conference some participants 
expressed concerns that the proposed amendments of CBM forms addressing assistance and 
cooperation activities could be understood as an approach for avoiding an open ended 
Article X discussion at the Conference. This is not the intention of the respective proposals. 
Germany, Norway and Switzerland as proponents of the respective proposals will be fully 
flexible for other approaches addressing assistance and cooperation. 
 II. Proposals for updating the CBM forms at the Seventh 
Review Conference 
6. The attached Annex contains a synopsis of all proposals for updating the existing 
Confidence Building Measures. The first column presents the original text (decisions of 
review conferences at adoption, modalities and forms) of the existing CBMs2. In the second 
column the proposed changes, deletions and amendments are marked in bold italics. The 
third column provides the rationale for the proposed changes. 
  
 2 Originally published as the Annex to the Final Declaration of the Third Review Conference 
(BWC/CONF.III/23), reproduced most recently as Annex I of BWC/CONF.VII/INF.1) 
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Annex 
A synopsis of proposals for updating the existing Confidence Building Measures 
Original Text Proposed Changes Rationale  
Confidence-Building Measure A Confidence-Building Measure A  
Part 1: Exchange of data on research centres and 
laboratories 
Part 1: Exchange of data on research centres and laboratories  
At the Third Review Conference it was agreed that 
States Parties continue to implement the following: 
At the [Third] Review Conference it was agreed that States Parties 
continue to implement the following: 
"Exchange of data, including name, location, scope 
and general description of activities, on research 
centres and laboratories that meet very high national 
or international safety standards established for 
handling, for permitted purposes, biological materials 
that pose a high individual and community risk or 
specialize in permitted biological activities directly 
related to the Convention." 
"Exchange of data, including name, location, scope and general description 
of activities, on research centres and laboratories that meet very high 
national or international safety standards established for handling, for 
permitted purposes, biological materials that pose a high individual and 
community risk or specialize in permitted biological activities directly 
related to the Convention." 
Annual declaration of 
facilities possessing maximum 
containment for work with 
human as well as animal 
pathogens is meanwhile 
common practice. It is 
proposed to update the 
language under “modalities” 
and in Form A, part 1 to cover 
this standard.  
Modalities Modalities  
The Third Review Conference agreed that data should 
be provided by States Parties on each facility, within 
their territory or under their jurisdiction or control 
anywhere, which has any maximum containment 
laboratories meeting those criteria for such maximum 
containment laboratories as specified in the 1983 
WHO Laboratory Biosafety Manual such as those 
designated as biosafety level 4 (BL4) or P4 or 
equivalent standards. 
The [Third] Review Conference agreed that data should be provided by 
States Parties on each facility, within their territory or under their 
jurisdiction or control anywhere, which has any maximum containment 
laboratories meeting those criteria for such maximum containment 
laboratories as specified in the 1983 latest version of the WHO3 Laboratory 
Biosafety Manual and/or the OIE4 Terrestrial Manual or other equivalent 
internationally accepted guidelines such as those designated as biosafety 
level 4 (BL4), BSL4 or P4 or equivalent standards.  
New WHO Laboratory 
Biosafety Manual version 
supersedes 1983 version. 
OIE Terrestrial Manual 
provides criteria for maximum 
containment with animal Risk 
Group 4 pathogens. 
  
 3 World Health Organization  
 4  World Organization for Animal Health 
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Original Text Proposed Changes Rationale  
 States Parties that do not possess a facility meeting criteria for such 
maximum containment should continue with Form A, part 1 (ii). 
See comments below. 
   
Form A, part 1 Form A, part 1 (i) Renumbering as a Form A, part 
1 (ii) will be added. 
Exchange of data on research centres and laboratories5 
1. Name(s) of facility6  
2. Responsible public or private organization 
or company 
3. Location and postal address 
4. Source(s) of financing of the reported 
activity, including indication if the activity is wholly 
or partly financed by the Ministry of Defence 
5. Number of maximum containment units7 
within the research centre and/or laboratory, with an 
indication of their respective size (m2)  
6. If no maximum containment unit, indicate 
highest level of protection  
7. Scope and general description of activities, 
including type(s) of micro-organisms and/or toxins as 
appropriate 
Exchange of data on research centres and laboratories8 
1. Name(s) of facility9 
2. Responsible public or private organization or company 
3. Location and postal address  
4. Source(s) of financing of the reported activity, including 
indication if the activity is wholly or partly financed by the Ministry of 
Defence 
5. Number of maximum containment units10 within the research 
centre and/or laboratory, with an indication of their respective size (m2) 
6. If no maximum containment unit, indicate highest level of 
protection  
7. 6. Scope and general description of activities, including type(s) 
of micro-organisms and/or toxins as appropriate   
7. Briefly describe the publication policy of the research centre 
and/or laboratory. 
8. Provide a list of publicly-available papers and reports resulting 
from the work published during the previous 12 months. (To include 
authors, titles and full references.) 
Old item 6 is deleted for 
giving reason for 
misinterpretation of the 
requirements set out in 
modalities. Requirement is 
declaration of BSL4 and not 
BSL3 or BSL2 laboratories. 
New items 7 and 8 are inserted 
for increasing transparency of 
work done at declared 
facilities. Insertion is in line 
with deletion of Form C. 
Inserted language is copied 
from item 4. (viii) of Form A, 
part 2 (iii) with the amendment 
“research centre and/or 
laboratory” and item 4. (ix) of 
Form A, part 2 (iii). 
  
 5 The containment units which are fixed patient treatment modules, integrated with laboratories, should be identified separately.  
 6 For facilities with maximum containment units participating in the national biological defence research and development programme, please fill in 
name of facility and mark "Declared in accordance with Form A, part 2 (iii)".  
 7 In accordance with the 1983 WHO Laboratory Biosafety Manual, or equivalent.   
 8 The containment units which are fixed patient treatment modules, integrated with laboratories, should be identified separately.  
 9 For facilities with maximum containment units participating in the national biological defence research and development programme, please fill in 
name of facility and mark “Declared in accordance with Form A, part 2 (iii)”.  
 10 In accordance with the 1983 latest version of the WHO Laboratory Biosafety Manual, the OIE Terrestrial Manual or other equivalent 
internationally accepted guidelines.   
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Original Text Proposed Changes Rationale  
 Form A, part 1 (ii) 
 If no BSL4 facility is declared in Form A, part 1 (i), indicate the highest 
biosafety level implemented in facilities handling biological agents11 on a 
State Party’s territory:  
  
 Biosafety level 212 yes / no  
 Biosafety level 310 yes / no 
  
New form in line with deletion 
of old item 6 of Form A, part 
1. Form shall provide 
opportunity to declare highest 
biosafety level implemented in 
facilities handling biological 
agents on a State Party’s 
territory when no BSL 4 
facility is declared. No listing 
of facilities is required only 
ticking of “yes” or “no”. 
   
Confidence-Building Measure A Confidence-Building Measure A  
Part 2: Exchange of information on national 
biological defence research and development 
programmes 
Part 1: Exchange of information on national biological defence 
research and development programmes (civil and military) for 
protection of humans, animals or plants against the hostile use of 
biological agents and toxins 
 
At the Third Review Conference it was agreed that 
States Parties are to implement the following: 
In the interest of increasing the transparency of 
national research and development programmes on 
biological defence, the States Parties will declare 
whether or not they conduct such programmes. States 
Parties agreed to provide, annually, detailed 
information on their biological defence research and 
development programmes including summaries of the 
objectives and costs of effort performed by contractors 
and in other facilities. If no biological defence 
research and development programme is being 
conducted, a null report will be provided. 
At the [Third] Review Conference it was agreed that States Parties are to 
implement the following: 
In the interest of increasing the transparency of national research and 
development programmes (civil and military) on biological defence for the 
protection of humans, animals and plants against the hostile use of 
biological agents and toxins, the States Parties will declare whether or not 
they conduct such programmes. States Parties agreed to provide, annually, 
detailed information on their biological defence research and development 
programmes (civil and military)  for the protection of humans, animals 
and plants against the hostile use of biological agents and toxins 
including summaries of the objectives and costs of effort performed by 
contractors and in other facilities. If no biological defence such research 
and development programme is being conducted, a null report will be 
provided. 
When Confidence Building 
Measure A part 2 was agreed 
in 1991 “biological defence 
research and development 
programmes” were understood 
to be solely military activities. 
After 9/11 and the Anthrax 
letters States Parties started 
activating in addition civil 
biological  defence research 
and development programmes. 
Some States Parties already 
now provide information on 
military and civil defence R+D 
programmes under CBM 
forms A part 2.  
  
 11 Microorganisms pathogenic to humans and/or  animals  
 12 In accordance with the latest version of the WHO Laboratory Biosafety Manual, the OIE Terrestrial Manual or other equivalent internationally 
accepted guidelines.  
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Original Text Proposed Changes Rationale  
States Parties will make declarations in accordance 
with the attached forms, which require the following 
information: 
(1)  The objective and summary of the 
research and development activities under way 
indicating whether work is conducted in the following 
areas: prophylaxis, studies on pathogenicity and 
virulence, diagnostic techniques, aerobiology, 
detection, treatment, toxinology, physical protection, 
decontamination and other related research; 
(2)  Whether contractor or other non-defence 
facilities are utilized and the total funding provided to 
that portion of the programme; 
(3)  The organizational structure of the 
programme and its reporting relationships; and 
(4)  The following information concerning the 
defence and other governmental facilities in which the 
biological defence research and development 
programme is concentrated; 
(a) location; 
(b) the floor areas (sqM) of the facilities 
including that dedicated to each of BL2, BL3 
and BL4 level laboratories; 
(c) the total number of staff employed, 
including those contracted full time for more 
than six months; 
(d) numbers of staff reported in (c) by the 
following categories: civilian, military, 
scientists, technicians, engineers, support and 
administrative staff; 
(e) a list of the scientific disciplines of the 
scientific/engineering staff; 
(f) the source and funding levels in the 
following three areas: research, development, 
and test and evaluation; and 
(g) the policy regarding publication and a list of 
publicly-available papers and reports. 
States Parties will make declarations in accordance with the attached forms, 
which require the following information: 
(1)  The objective and summary of the research and development 
activities under way indicating whether work is conducted in the following 
areas: prophylaxis, studies on pathogenicity and virulence, diagnostic 
techniques, aerobiology, detection, treatment, toxinology, physical 
protection, decontamination and other related research; 
(2)  Whether contractor or other non-defence facilities are utilized 
and the total funding provided to that portion of the programme; 
(3) The organizational structure of the programme and its reporting 
relationships; and 
(4)  The following information concerning the defence and other 
governmental facilities in which the biological defence research and 
development programme (civil and military) for the protection of humans, 
animals and plants against the hostile use of biological agents and toxins 
is concentrated; 
(a) location; 
(b) the floor areas (sqM) of the facilities including that dedicated to 
each of BL2, BL3 and BL4 level laboratories; 
(c) the total number of staff employed, including those contracted 
full time for more than six months; 
(d) numbers of staff reported in (c) by the following categories: 
civilian, military, scientists, technicians, engineers, support and 
administrative staff; 
(e) a list of the scientific disciplines of the scientific/engineering 
staff; 
(f) the source and funding levels in the following three areas: 
research, development, and test and evaluation; and 
(g) the policy regarding publication and a list of publicly-available 
papers and reports. 
 
The proposed language 
extends the requirement to 
report under this CBM not 
only on military but also on 
other R+D programmes for the 
protection of humans, animals 
and plants against the hostile 
use of biological agents and 
toxins. “Hostile use” is a clear 
allusion to Article I of the 
Convention and covers both 
State and non-State actors. 
The language change is 
equally applicable to CBM A, 
part 2 and Forms A, part 2 (i), 
(ii) and (iii). 
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Original Text Proposed Changes Rationale  
Form A, part 2 (i) Form A, part 2 (i)  
National Biological Defence Research and 
Development Programme Declaration 
National Biological Defence Research and Development Programme 
(civil and military)  for Protection of Humans, Animals or Plants 
Against the Hostile Use of Biological Agents and Toxins Declaration 
 
Is there a national programme to conduct biological 
defence research and development within the territory 
of the State Party, under its jurisdiction or control 
anywhere?  
Activities of such a programme would include 
prophylaxis, studies on pathogenicity and virulence, 
diagnostic techniques, aerobiology, detection, 
treatment, toxinology, physical protection, 
decontamination and other related research. 
Is there a national programme to conduct biological defence research and 
development (civil and military)  for the protection of humans, animals 
and plants against the hostile use of biological agents and toxins within 
the territory of the State Party, under its jurisdiction or control anywhere? 
Activities of such a programme would include prophylaxis, studies on 
pathogenicity and virulence, diagnostic techniques, aerobiology, detection, 
treatment, toxinology, physical protection, decontamination and other 
related research. 
 
Yes/No Yes/No  
If the answer is Yes, complete Form A, part 2 (ii) 
which will provide a description of the programme. 
If the answer is Yes, complete Form A, part 2 (ii) which will provide a 
description of the programme. 
 
   
Form A, part 2 (ii) Form A, part 2 (ii)  
National biological defence research and 
development programme 
National biological defence research and development programme 
(civil and military) for protection of humans, animals or plants against 
the hostile use of biological agents and toxins  
 
Description Description  
1. State the objectives and funding of the 
programme and summarize the principal research and 
development activities conducted in the programme. 
Areas to be addressed shall include: prophylaxis, 
studies on pathogenicity and virulence, diagnostic 
techniques, aerobiology, detection, treatment, 
toxinology, physical protection, decontamination and 
other related research. 
1. State the objectives and funding of the each  programme and 
summarize the principal research and development activities conducted in 
the programme. Areas to be addressed shall include: prophylaxis, studies 
on pathogenicity and virulence, diagnostic techniques, 
aerobiology, detection, treatment, toxinology, physical protection, 
decontamination and other related research. 
 
2. State the total funding for the programme 
and its source. 
2. State the total funding for the each programme and its source.  
3. Are aspects of this programme conducted 
under contract with industry, academic institutions, or 
in other non-defence facilities?  Yes/No  
3. Are aspects of this these programmes conducted under contract 
with industry, academic institutions, or in other non-defence facilities?  
Yes/No 
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Original Text Proposed Changes Rationale  
4. If yes, what proportion of the total funds for 
the programme is expended in these contracted or 
other facilities? 
4. If yes, what proportion of the total funds for the programmes is 
expended in these contracted or other facilities? 
 
5. Summarize the objectives and research 
areas of the programme performed by contractors and 
in other facilities with the funds identified under 
paragraph 4. 
5. Summarize the objectives and research areas of the programmes 
performed by contractors and in other facilities with the funds identified 
under paragraph 4. 
 
6. Provide a diagram of the organizational 
structure of the programme and the reporting 
relationships (include individual facilities participating 
in the programme). 
 
6. Provide a diagram of the organizational structure of the each 
programme (civil and military) and the reporting relationships (include 
individual facilities participating in the programme). 
 
 7.  Describe the internal, i.e. within the organizational structures 
provided by the diagram above, and external, i.e. outside those structure, 
oversight mechanisms designed to compliance with the treaty obligations, 
as implemented nationally. 
7. Provide a declaration in accordance with 
Form A, part 2 (iii) for each facility, both 
governmental and non-governmental, which has a 
substantial proportion of its resources devoted to the 
national biological defence research and development 
programme, within the 
territory of the reporting State, or under its 
jurisdiction or control anywhere. 
7. 8. Provide a declaration in accordance with Form A, part 2 (iii) 
for each facility, both governmental and non-governmental, which has a 
substantial proportion of its resources devoted to the national biological 
defence research and development programme (civil and military) for the 
protection of humans, animals and plants against the hostile use of 
biological agents and toxins, within the territory of the reporting State, or 
under its jurisdiction or control anywhere. 
The insertion of a new item 7. 
is based on discussions at the 
intersessional process for 
providing information on 
oversight of research and 
development programmes for 
the protection of humans, 
animals and plants against the 
hostile use of biological agents 
and toxins. 
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Original Text Proposed Changes Rationale  
Form A, part 2 (iii) Form A, part 2 (iii)  
National biological defence research and 
development programme 
National biological defence research and development programme (civil 
and military) for protection of humans, animals or plants against the 
hostile use of biological agents and toxins  
 
Facilities Facilities  
Complete a form for each facility declared in 
accordance with paragraph 7 in Form A, part 2 (ii). 
In shared facilities, provide the following information 
for the biological defence research and development 
portion only. 
Complete a form for each facility declared in accordance with paragraph 7 8. 
in Form A, part 2 (ii). 
In shared facilities, provide the following information for the biological 
defence research and development for the protection of humans, animals 
and plants against the hostile use of biological agents and toxins portion 
only. 
 
1. What is the name of the facility? 1. What is the name of the facility?  
2. Where is it located (include both address and 
geographical location)? 
2. Where is it located (include both address and geographical location)?  
3. Floor area of laboratory areas by containment level: 
BL2 (sqM) 
BL3  (sqM) 
BL4  (sqM) 
Total laboratory floor area (sqM) 
3. Floor area of laboratory areas by containment level: 
BL2 (sqM) 
BL3  (sqM) 
BL4  (sqM) 
Total laboratory floor area (sqM) 
 
4. The organizational structure of each facility. 
(i) Total number of personnel  
(ii) Division of personnel: 
Military  
Civilian  
(iii) Division of personnel by category: 
Scientists  
Engineers 
Technicians  
Administrative and support staff  
4. The organizational structure of each facility. 
(i) Total number of personnel  
(ii) Division of personnel: 
Military  
Civilian  
(iii) Division of personnel by category: 
Scientists  
Engineers 
Technicians  
Administrative and support staff  
Minor amendment to clarify 
that listed publications should 
be published during the period 
covered by the CBM 
submission. 
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(iv) List the scientific disciplines represented in 
the scientific/engineering staff. 
(v) Are contractor staff working in the facility? 
If so, provide an approximate number  
(vi) What is (are) the source(s) of funding for 
the work conducted in the facility, including indication 
if activity is wholly or partly financed by the Ministry 
of Defence?  
(vii) What are the funding levels for the 
following programme areas:  
Research  
Development  
Test and evaluation  
(viii) Briefly describe the publication policy of 
the facility: 
(ix) Provide a list of publicly-available papers 
and reports resulting from the work during the previous 
12 months. (To include authors, titles and full 
references.)  
(iv) List the scientific disciplines represented in the 
scientific/engineering staff. 
(v) Are contractor staff working in the facility? If so, provide an 
approximate number  
(vi) What is (are) the source(s) of funding for the work conducted in 
the facility, including indication if activity is wholly or partly financed by the 
Ministry of Defence?  
(vii) What are the funding levels for the following programme areas:  
Research  
Development  
Test and evaluation  
(viii) Briefly describe the publication policy of the facility: 
(ix) Provide a list of publicly-available papers and reports resulting 
from the work published during the previous 12 months. (To include authors, 
titles and full references.) 
5. Briefly describe the biological defence work carried 
out at the facility, including type(s) of micro-
organisms13Gand/or toxins studied, as well as outdoor 
studies of biological aerosols. 
5. Briefly describe the biological defence work for the protection of 
humans, animals and plants against the hostile use of biological agents 
and toxins carried out at the facility, including type(s) of micro-
organisms11Gand/or toxins studied, as well as indoor and outdoor studies of 
biological aerosols. 
The insertion of “indoor and” 
serves the purpose clarifying 
that not only information on 
outdoor studies are requested. 
   
  
 13 including viruses and prions  
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Original Text Proposed Changes Rationale  
Confidence-Building Measure B Confidence-Building Measure B  
Exchange of information on outbreaks of 
infectious diseases and similar occurrences 
caused by toxins 
Exchange of information on outbreaks of infectious diseases and similar 
occurrences caused by toxins 
 
At the Third Review Conference it was agreed that 
States Parties continue to implement the following: 
Exchange of information on outbreaks of infectious 
diseases and similar occurrences caused by toxins, and 
on all such events that seem to deviate from the 
normal pattern as regards type, development, place, or 
time of occurrence. The information provided on 
events that deviate from the norm will include, as soon 
as it is available, data on the type of disease, 
approximate area affected, and number of cases. 
At the [Third] Review Conference it was agreed that States Parties 
continue to implement the following: 
exchange of information on outbreaks of infectious diseases and similar 
occurrences caused by toxins, and on all such events that seem to deviate 
from the normal pattern as regards type, development, place, or time of 
occurrence. The information provided on events that deviate from the norm 
will include, as soon as it is available, data on the type of disease, 
approximate area affected, and number of cases. 
The deletion of “, and on all 
such events” is linked to the 
proposal to delete Form B(i). 
The original sentence connects 
the two requests for filling 
forms B (i) and B (ii). With 
the proposed deletion of  Form 
B (i) the connecting language 
“, and on all such events” is no 
more required. 
Modalities Modalities  
The Third Review Conference agreed the following 
definition: 
An outbreak or epidemic is the occurrence of an 
unusually large or unexpected number of cases of an 
illness or health-related event in a given place at a 
given time. The number of cases considered as 
unusual will vary according to the illness or event and 
the community concerned. 
The [Third] Review Conference agreed the following definition: 
An outbreak or epidemic is the occurrence of an unusually large or 
unexpected number of cases of an illness or health-related event in a given 
place at a given time. The number of cases considered as unusual will vary 
according to the illness or event and the community concerned. 
 
Furthermore, reference was made to the following 
definitions: 
An epidemic of infectious disease is defined as the 
occurrence of an unusually large or unexpected 
number of cases of a disease known or suspected to be 
of infectious origin, for a given place and time. It is 
usually a rapidly evolving situation, requiring a rapid 
response (WHO internal document CDS/Mtg/82.1).  
Furthermore, reference was made to the following definitions: 
An epidemic of infectious disease is defined as the occurrence of an 
unusually large or unexpected number of cases of a disease known or 
suspected to be of infectious origin, for a given place and time. It is usually 
a rapidly evolving situation, requiring a rapid response (WHO internal 
document CDS/Mtg/82.1).  
 
The occurrence in a community or region of cases of 
an illness, specific health-related behaviour, or other 
health-related events clearly in excess of normal 
expectancy. The community or region, and the time 
The occurrence in a community or region of cases of an illness, specific 
health-related behaviour, or other  
health-related events clearly in excess of normal expectancy. The 
community or region, and the time period in which the cases occur, are 
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period in which the cases occur, are specified 
precisely. The number of cases indicating the presence 
of an epidemic will vary according to the agent, size 
and type of population exposed, previous experience 
or lack of exposure to the disease, and time and place 
of occurrence: epidemicity is thus relative to usual 
frequency of the disease in the same area, among the 
specified population, at the same season of the year. A 
single case of a communicable disease long absent 
from a population or first invasion by a disease not 
previously recognized in that area requires immediate 
reporting and full field investigation: two cases of 
such a disease associated in time and place may be 
sufficient evidence to be considered an epidemic. 
(J.M. Last, A Dictionary of Epidemiology, Oxford 
University Press, New York, Oxford, Toronto, 1983.) 
specified precisely. The number of cases indicating the presence of an 
epidemic will vary according to the agent, size and type of population 
exposed, previous experience or lack of exposure to the disease, and time 
and place of occurrence: epidemicity is thus relative to usual frequency of 
the disease in the same area, among the specified population, at the same 
season of the year. A single case of a communicable disease long absent 
from a population or first invasion by a disease not previously recognized 
in that area requires immediate reporting and full field investigation: two 
cases of such a disease associated in time and place may be sufficient 
evidence to be considered an epidemic. (J.M. Last, A Dictionary of 
Epidemiology, Oxford University Press, New York, Oxford, Toronto, 
1983.) 
 
The Third Review Conference agreed on the 
following: 
The [Third] Review Conference agreed on the following:  
1.  In determining what constitutes an outbreak 
States Parties are recommended to take guidance from 
the above. 
1. In determining what constitutes an outbreak States Parties are 
recommended to take guidance from the above. 
 
2.  Since no universal standards exist for what 
might constitute a deviation from the normal pattern, 
States Parties agreed to utilize fully existing national 
reporting systems on human diseases as well as animal 
and plant diseases, where possible, and systems within 
the WHO to provide annual update of background 
information on diseases caused by organisms which 
meet the criteria for risk groups II, III and IV 
according to the classification in the 1983 WHO 
Laboratory Biosafety Manual, the occurrence of 
which, in their respective areas, does not necessarily 
constitute a deviation from normal patterns.14 
2. Since no universal standards exist for what might constitute a 
deviation from the normal pattern, States Parties agreed to utilize fully 
existing national reporting systems on human diseases as well as animal 
and plant diseases, where possible, and systems within the WHO to 
provide annual update of background information on diseases caused by 
organisms which meet the criteria for risk groups II, III and IV 
according to the classification in the 1983  WHO Laboratory Biosafety 
Manual, the occurrence of which, in their respective areas, does not 
necessarily constitute a deviation from normal patterns.12 
Old item 2 sets the scope for 
providing annual update of 
background information on 
diseases for being provided in 
Form B (i). With the proposed 
deletion of Form B (i) old item 
2. is no longer required. 
3.  Exchange of data on outbreaks that seem to 
deviate from the normal pattern is considered 
3  2.  Exchange of data on outbreaks that seem to deviate from the 
normal pattern is considered particularly important in the following cases: 
Technical change: only one 
footnote survives. 
  
 14 This information should be provided in accordance with Form B (I).  
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particularly important in the following cases: 
- When the cause of the outbreak cannot be 
readily determined or the causative agent15Gis difficult 
to diagnose, 
- When the disease may be caused by 
organisms which meet the criteria for risk groups III 
or IV, according to the classification in the 1983 WHO 
Laboratory Biosafety Manual, 
- When the causative agent is exotic to a given 
region, 
- When the disease follows an unusual pattern 
of development, 
- When the disease occurs in the vicinity of 
research centres and laboratories subject to exchange 
of data under item A, 
- When suspicions arise of the possible 
occurrence of a new disease. 
- When the cause of the outbreak cannot be readily determined or 
the causative agent13 is difficult to diagnose, 
- When the disease may be caused by organisms which meet the 
criteria for risk groups III or IV, according to the classification in the 1983 
latest version of the WHO Laboratory Biosafety Manual, 
- When the causative agent is exotic to a given geographical 
region, 
- When the disease follows an unusual pattern of development, 
- When the disease occurs in the vicinity of research centres and 
laboratories subject to exchange of data under item A, 
- When suspicions arise of the possible occurrence of a new 
disease. 
 
Technical change: new version 
superseded the 1983 edition. 
Clarification that region means 
“geographical region”. 
 
4.  In order to enhance confidence, an initial 
report of an outbreak of an infectious disease or a 
similar occurrence that deviate from the normal 
pattern should be given promptly after cognizance of 
the outbreak and should be followed up by annual 
reports. 
4  3.  In order to enhance confidence, an initial report of an 
outbreak of an infectious disease or a similar occurrence that deviate from 
the normal pattern should be given promptly after cognizance of the 
outbreak and should be followed up by annual reports. 
 
To enable States Parties to follow a standardized 
procedure, the Conference has agreed that Form B (ii) 
should be used, to the extent information is known 
and/or applicable, for the exchange of initial as well as 
annual information. 
To enable States Parties to follow a standardized procedure, the Conference 
has agreed that Form B (ii) should be used, to the extent information is 
known  and/or applicable, for the exchange of initial as well as annual 
information. 
Technical change: only one 
Form B survives. 
 The declaration of electronic links to national websites or to websites of 
international (WHO, OIE) or other organizations (GOARN, PROMED 
that provide information on disease outbreaks may also satisfy the 
declaration requirement under Form B. 
New language allowing use of 
information on disease 
outbreaks available on the 
Internet instead of filling the 
scheme provided under Form 
B. 
5.  In order to improve international 5  4.  In order to improve international cooperation in the field of  
  
 15 It is understood that this may include organisms made pathogenic by molecular biology techniques, such as genetic engineering.  
  
B
W
C
/C
O
N
F.V
II/W
P.9 
14 Original Text Proposed Changes Rationale  
cooperation in the field of peaceful bacteriological 
(biological) activities and in order to prevent or reduce 
the occurrence of ambiguities, doubts and suspicions, 
States Parties are encouraged to invite experts from 
other States Parties to assist in the handling of an 
outbreak, and to respond favourably to such 
invitations. 
peaceful bacteriological (biological) activities and in order to prevent or 
reduce the occurrence of ambiguities, doubts and suspicions, States Parties 
are encouraged to invite experts from other States Parties to assist in the 
handling of an outbreak, and to respond favourably to such invitations. 
   
Form B (i) Form B (i)  
Background information on outbreaks of 
reportable infectious diseases 
Background information on outbreaks of reportable infectious 
diseases 
 
 Number of cases per year   Number of cases per year 
 1988 1989 1990 1991 1992   1988 1989 1990 1991 1992 
Diseases       Diseases      
CBM declarations show that 
States Parties provide under B 
(i) more irrelevant than 
relevant background data. In 
most cases better information 
today is available on 
theInternet, therefore deletion 
is proposed. 
   
Form B (ii) Form B (ii)  
Information on outbreaks of infectious diseases 
and similar occurrences, that seem to deviate 
from the normal pattern 
Information on outbreaks of infectious diseases and similar 
occurrences, that seem to deviate from the normal pattern 
Technical change: only one 
Form B survives. 
 Use the following declaration scheme or when available notify links to 
national websites and/or websites of international (WHO, OIE) or and 
other organizations (GOARN, PROMED) that provide information on 
outbreaks of infectious diseases and similar occurrences, that seem to 
deviate from the normal pattern 
1.  Time of cognizance of the outbreak 1. Time of cognizance of the outbreak 
2.  Location and approximate area affected 2. Location and approximate area affected 
Notification of or reports on 
outbreaks of diseases are 
today publicly accessible on 
the Internet. The provision of 
weblinks on outbreaks is 
estimated to provide sufficient 
information under Form B. In 
cases in which no weblink is 
available or additional 
information is deemed to be 
necessary the old form may be 
filled. 
3.  Type of disease/intoxication 3. Type of disease/intoxication  
4.  Suspected source of disease/intoxication 4. Suspected source of disease/intoxication  
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5.  Possible causative agent(s) 5. Possible causative agent(s)  
6.  Main characteristics of systems 6. Main characteristics of systems  
7.  Detailed symptoms, when applicable 
- respiratory 
- circulatory 
- neurological/behavioural 
- intestinal 
- dermatological 
- nephrological 
- other 
7. Detailed symptoms, when applicable 
- respiratory 
- circulatory 
- neurological/behavioural 
- intestinal 
- dermatological 
- nephrological 
- other 
 
8. Deviation(s) from the normal pattern as 
regards 
- type 
- development 
- place of occurrence 
- time of occurrence 
- symptoms 
- virulence pattern 
- drug resistance pattern 
- agent(s) difficult to diagnose 
- presence of unusual vectors 
- other 
8. Deviation(s) from the normal pattern as regards 
- type 
- development 
- place of occurrence 
- time of occurrence 
- symptoms 
- virulence pattern 
- drug antimicrobial/pesticide resistance pattern 
- agent(s) difficult to diagnose 
- presence of unusual vectors  
- other 
Clarification: the terms 
“antimicrobial and pesticide” 
resistance may better reflect 
than “drug” resistance what is 
meant here. 
9.  Approximate number of primary cases 9. Approximate number of primary cases  
10.  Approximate number of total cases 10. Approximate number of total cases  
11.  Number of deaths 11. Number of deaths  
12.  Development of the outbreak 12. Development of the outbreak  
13.  Measures taken 13. Measures taken  
 14. Assistance requested:    yes / no 
 15. Assistance received:    yes / no 
Amendment meeting 
assistance aspects of disease 
outbreaks. 
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Confidence Building Measure C Confidence Building Measure C  
Encouragement of publication of results and 
promotion of use of knowledge 
Encouragement of publication of results and promotion of use of 
knowledge 
 
At the Third Review Conference it was agreed that 
States parties continue to implement the following: 
"Encouragement of publication of results of biological 
research directly related to the Convention, in 
scientific journals generally available to States parties, 
as well as promotion of use for permitted purposes of 
knowledge gained in this research." 
At the Third Review Conference it was agreed that States parties 
continue to implement the following: 
"Encouragement of publication of results of biological research directly 
related to the Convention, in scientific journals generally available to 
States parties, as well as promotion of use for permitted purposes of 
knowledge gained in this research." 
Modalities Modalities 
The Third Review Conference agreed on the 
following: 
The Third Review Conference agreed on the following: 
1.  It is recommended that basic research in 
biosciences, and particularly that directly related to 
the Convention should generally be unclassified and 
that applied research to the extent possible, without 
infringing on national and commercial interests, 
should also be unclassified. 
1.  It is recommended that basic research in biosciences, and 
particularly that directly related to the Convention should generally be 
unclassified and that applied research to the extent possible, without 
infringing on national and commercial interests, should also be 
unclassified. 
2.  States parties are encouraged to provide 
information on their policy as regards publication of 
results of biological research, indicating, inter alia, 
their policies as regards publication of results of 
research carried out in research centres and 
laboratories subject to exchange of information under 
item A and publication of research on outbreaks of 
diseases covered by item B, and to provide 
information on relevant scientific journals and other 
relevant scientific publications generally available to 
States parties. 
2.  States parties are encouraged to provide information on their 
policy as regards publication of results of biological research, indicating, 
inter alia, their policies as regards publication of results of research 
carried out in research centres and laboratories subject to exchange of 
information under item A and publication of research on outbreaks of 
diseases covered by item B, and to provide information on relevant 
scientific journals and other relevant scientific publications generally 
available to States parties. 
3.  The Third Review Conference discussed 
the question of cooperation and assistance as regards 
the safe handling of biological material covered by the 
Convention. It concluded that other international 
forums were engaged in this field and expressed its 
support for efforts aimed at enhancing such 
cooperation. 
3.  The Third Review Conference discussed the question of 
cooperation and assistance as regards the safe handling of biological 
material covered by the Convention. It concluded that other international 
forums were engaged in this field and expressed its support for efforts 
aimed at enhancing such cooperation. 
Form C was agreed in 1991.  
With the development of the 
Internet within the last two 
decades research results 
published in scientific journals 
are now generally available in 
the world wide web. For this 
reason deletion of Form C is 
proposed. 
Scientific publications and 
reports linked with declared 
facilities under Form A, part 2 
(iii) will be reported under 
item 4. (ix) of  Form A, part 2 
(iii). 
For linking scientific 
publications and reports also 
with declared BSL 4 facilities, 
insertion of new items 7. and 
8. in Form A, part 1 (i) is 
proposed. (see page 2). 
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Confidence Building Measure D Confidence Building Measure D  
Active promotion of contacts Active promotion of contacts  
At the Third Review Conference it was agreed that 
States parties continue to implement the following: 
"Active promotion of contacts between scientists, 
other experts and facilities engaged in biological 
research directly related to the Convention, including 
exchanges and visits for joint research on a mutually 
agreed basis." 
At the [Third] Review Conference it was agreed that States parties continue 
to implement the following: 
"Active promotion of contacts between scientists, other experts and 
facilities engaged in biological research directly related to the Convention, 
including exchanges and visits for joint research on a mutually agreed 
basis." 
 
Modalities Modalities  
The Third Review Conference agreed on the 
following: 
In order to actively promote professional contacts 
between scientists, joint research projects and other 
activities aimed at preventing or reducing the 
occurrence of ambiguities, doubts and suspicions and 
at improving international cooperation in the field of 
peaceful bacteriological (biological) activities, States 
parties are encouraged to provide information, to the 
extent possible: 
The [Third] Review Conference agreed on the following: 
In order to actively promote professional contacts between scientists, joint 
research projects and other activities aimed at preventing or reducing the 
occurrence of ambiguities, doubts and suspicions and at improving 
international cooperation in the field of peaceful bacteriological 
(biological) activities, States parties are encouraged to provide forward 
looking information, to the extent possible: 
Clarification, as often historic 
data are declared. 
-  on planned international conferences, 
seminars, symposia and similar events dealing with 
biological research directly related to the Convention, 
-  on planned international conferences, seminars, symposia and 
similar events dealing with biological research directly related to the 
Convention, 
 
-  on other opportunities for exchange of 
scientists, joint research or other measures to promote 
contacts between scientists engaged in biological 
research directly related to the Convention. 
-  on other opportunities for exchange of scientists, joint research or 
other measures to promote contacts between scientists engaged in 
biological research directly related to the Convention. 
 
To enable States parties to follow a standardized 
procedure, the Third Review Conference has agreed 
that Form D should be used for exchange of 
information under this item. 
To enable States parties to follow a standardized procedure, the Third 
Review Conference has agreed that Form D should be used for exchange of 
information under this item. 
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Form D Form D  
Active promotion of contacts Active promotion of contacts  
1.  Planned international conferences, 
symposia, seminars, and other similar forums for 
exchange. For each such event, the following 
information should be provided: 
- name of the conference, etc 
- arranging organization(s), etc. 
- time 
- place 
- main subject(s) for the conference, etc. 
- conditions for participation 
- point of contact for further information, 
registration, etc. 
1.  Planned international conferences, symposia, seminars, and 
other similar forums for exchange. For each such event, the following 
information should be provided: 
- name of the conference, etc 
- arranging organization(s), etc. 
- time 
- place 
- main subject(s) for the conference, etc. 
- conditions for participation 
- point of contact for further information, registration, etc. 
 
2.  Information regarding other opportunities 2.  Information regarding other opportunities, i.e. inter alia areas in 
which cooperation  would be welcomed/ could be offered, including 
indicating a point of contact or others 
Clarification 
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Confidence Building Measure E Confidence Building Measure E  
Declaration of legislation, regulations and other 
measures 
Declaration of legislation, regulations and other measures  
At the Third Review Conference the States parties 
agreed to implement the following: 
As an indication of the measures which they have 
taken to implement the Convention, States parties 
shall declare whether they have legislation, regulations 
or other measures: 
At the [Third] Review Conference the States parties agreed to implement 
the following: 
As an indication of the measures which they have taken to implement the 
Convention, States parties shall declare whether they have legislation, 
regulations or other measures: 
 
(a) To prohibit the development, production, 
stockpiling, acquisition or retention of microbial or 
other biological agents, or toxins, weapons, equipment 
and means of delivery, specified in Article I of the 
Convention, within their territory or anywhere under 
their jurisdiction or control; 
(a) To prohibit and prevent  the development, production, 
stockpiling, acquisition or retention of microbial or other biological agents, 
or toxins, weapons, equipment and means of delivery, specified in Article I 
of the Convention, within their territory or anywhere under their 
jurisdiction or control; 
"to prevent" is added as 
insertions below focus also on 
prevention and not only on 
prohibitions. 
(b) In relation to the export or import of 
micro-organisms pathogenic to man, animals and 
plants or of toxins in accordance with the Convention;  
(b) In relation to  
- the export or import of micro-organisms pathogenic to man, 
animals and plants or of toxins in accordance with the Convention; 
- biosafety and biosecurity measures; 
- principles, guidelines, codes , awareness raising and educational 
programmes addressing the “dual use” problem; 
See below 
States parties shall complete the attached form (Form 
E) and shall be prepared to submit copies of the 
legislation or regulations, or written details of other 
measures on request to the United Nations Department 
for Disarmament Affairs or to an individual State 
party. On an annual basis States parties shall indicate, 
also on the attached form, whether or not there has 
been any amendment to their legislation, regulations 
or other measures. 
States parties shall complete the attached form (Form E) and shall be 
prepared to submit copies of the legislation or regulations, or written details 
of other measures on request to the United Nations Department Office  for 
Disarmament Affairs or to an individual State party. On an annual basis 
States parties shall indicate, also on the attached form, whether or not there 
has been any amendment to their legislation, regulations or other measures. 
States Parties should indicate areas in which assistance to further 
implementation of legislation, regulations and/or other measures would 
be welcomed or could be offered, providing a point of contact to whom 
such offers might be directed. 
Delete “on request” for 
allowing ISU to build up a 
legislative database. 
Technical change: Former 
UNDDA is now UNODA 
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Form E Form E  
Declaration of legislation, regulations and other 
measures 
Declaration of legislation, regulations and other measures  
 
Legislation Regulations
Other  
measures
Amended 
since last 
year 
  
Legislation Regulations
Other  
measures 
Amended 
since last 
year 
(a) 
Development, 
production, 
stockpiling, 
acquisition 
……specified 
in Article I 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
 
(a) Development, 
production, stockpiling, 
acquisition specified in 
Article I 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
(b) Exports of 
micro-
organisms16 
and toxins 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
 
(b) Exports of micro-
organisms14 and toxins 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
(c) Imports of 
micro-
organisms14 
and toxins 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
 
(c) Imports of micro-
organisms14 and toxins 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
 
 
(d) Biosafety measures17 
Yes/ 
No o 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
 (e) Biosecurity 
measures18 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
Yes/ 
No 
 
 (f) Principles, 
guidelines, codes , 
awareness raising and 
educational 
programmes addressing 
the “dual use” problem   
Yes/ 
No  
Based on issues discussed at 
the intersessional process and 
estimated being relevant in 
supporting effective 
implementation of the 
Convention, the extension of 
Form E is proposed. 
  
 16 Micro-organisms pathogenic to man, animals and plants in accordance with the Convention  
 17 In accordance with the latest version of the WHO Laboratory Biosafety Manual  
 18 In accordance with the latest version of the WHO Laboratory Biosecurity Guidance  
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 (g) Indicate areas in which assistance for implementation of 
legislation, regulations and/or other measures would be welcomed, 
including a point of contact to whom such offers might be directed 
 
 (h) Indicate areas in which assistance  for implementation of 
legislation, regulations and/or other measures could be provided, 
including a point of contact from whom such assistance may be 
requested 
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Confidence Building Measure F Confidence Building Measure F  
Declaration of past activities in offensive and/or 
defensive biological research and development 
programmes 
Declaration of past activities in offensive and/or defensive biological 
research and development programmes 
 
In the interest of increasing transparency and 
openness, States parties shall declare whether or not 
they conducted any offensive and/or defensive 
biological research and development programmes 
since 1 January 1946. 
In the interest of increasing transparency and openness, States parties shall 
declare whether or not they conducted any offensive and/or defensive 
biological research and development programmes since 1 January 1946. 
 
If so, States parties shall provide information on such 
programmes, in accordance with Form F. 
If so, States parties shall provide information on such programmes, in 
accordance with Form F. 
 
   
Form F Form F  
Declaration of past activities in offensive and/or 
defensive biological research and development 
programmes 
Declaration of past activities in offensive and/or defensive biological 
research and development programmes 
 
1.  Date of entry into force of the Convention 
for the State party. 
1.  Date of entry into force of the Convention for the State party. No change proposed. Form F 
should be retained as it is. 
2.  Past offensive biological research and 
development programmes: 
- Yes - No 
- Period(s) of activities 
- Summary of the research and development 
activities indicating whether work was 
performed concerning production, test and 
evaluation, weaponization, stockpiling of 
biological agents, the destruction programme 
of such agents and weapons, and other related 
research. 
2.  Past offensive biological research and development 
programmes: 
- Yes - No 
- Period(s) of activities 
- Summary of the research and development activities indicating 
whether work was performed concerning production, test and 
evaluation, weaponization, stockpiling of biological agents, the 
destruction programme of such agents and weapons, and other 
related research. 
 
3.  Past defensive biological research and 
development programmes: 
- Yes - No 
- Period(s) of activities 
- Summary of the research and development 
activities indicating whether or not work was 
conducted in the following areas: prophylaxis, 
studies on pathogenicity and virulence, 
3.  Past defensive biological research and development 
programmes: 
- Yes - No 
- Period(s) of activities 
- Summary of the research and development activities indicating 
whether or not work was conducted in the following areas: 
prophylaxis, studies on pathogenicity and virulence, diagnostic 
techniques, aerobiology, detection, treatment, toxinology, physical 
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diagnostic techniques, aerobiology, detection, 
treatment, toxinology, physical protection, 
decontamination, and other related research, 
with location if possible. 
protection, decontamination, and other related research, with 
location if possible. 
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Confidence Building Measure G Confidence Building Measure G 
Declaration of vaccine production facilities Declaration of vaccine production facilities 
To further increase the transparency of biological 
research and development related to the Convention and 
to broaden scientific and technical knowledge as agreed 
in Article X, each State party will declare all facilities, 
both governmental and non-governmental, within its 
territory or under its jurisdiction or control anywhere, 
producing vaccines licensed by the State party for the 
protection of humans. Information shall be provided on 
Form G attached. 
To further increase the transparency of biological research and development 
related to the Convention and to broaden scientific and technical knowledge 
as agreed in Article X, each State party will declare all facilities, both 
governmental and non-governmental, within its territory or under its 
jurisdiction or control anywhere, producing vaccines licensed by a central 
agency of the State Party for the protection of humans and/or animals. 
Information shall be provided on Form G (i) and (ii) attached. 
Annual CBM declaration of 
production facilities for 
human and animal vaccines is 
meanwhile common practice. 
It is proposed to update the 
language to make it a common 
standard.  
Clarification is necessary as 
most animal vaccines are 
produced in small herd/stable 
batches without being licensed 
for general marketing of 
animal vaccines. Only 
production facilities holding 
licenses for general marketing 
should be declared. 
   
Form G Form G (i)  
Declaration of vaccine production facilities Declaration of vaccine production facilities for human vaccines 
1. Name of facility: 1. Name of facility: 
2. Location (mailing address): 2. Location (mailing address): 
3. General description of the types of diseases 
covered: 
3. General description of the types of diseases covered: 
Technical change caused by 
splitting Form G in sections 
for vaccines preventing human 
diseases and vaccines 
preventing animal diseases. 
   
 Form G (ii)  
 Declaration of production facilities for animal vaccines  
 1. Name of facility:  
 2. Location (mailing address):  
 3. General description of the types of diseases covered:  
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Confidence Building Measure 0 Confidence Building Measure 0  
Declaration form on Nothing to Declare or 
Nothing New to Declare for use in the 
information exchange 
Declaration form on Nothing to Declare or Nothing New to Declare 
for use in the information exchange 
 
 
Nothing to 
declare 
Nothing new to 
declare 
  
Nothing to 
declare 
Nothing new 
to declare 
Indicate year of 
last declaration 
if “Nothing 
new to declare” 
Measure    Measure    
A, part 1    A, part 1 (i)    
A, part 2 (i)    A, part 1 (ii)    
A, part 2 (ii)    A, part 2 (i)    
A, part 2 (iii)    A, part 2 (ii)    
B (i)    A, part 2 (iii)    
B (ii)    B (i)    
C    B (ii)    
D    C    
E    D    
F    E    
G    F    
Insertions and deletions in 
column “Measure” according 
to above proposed changes. 
New column “Indicate year of 
last declaration if “Nothing 
new to declare” is proposed 
for improving the assessment 
of  submitted CBMs by 
enabling (also electronic) links 
between the different annual 
declarations of a State Party. 
 G (i)     
 G (ii)    
 
(Please mark the appropriate box(es) for each 
measure, with a tick.) 
(Please mark the appropriate box(es) for each measure, with a tick and fill 
in the year of last declaration in the last column where applicable.) 
Clarification 
Date: Date:  
State Party to the Convention: State Party to the Convention:  
 Date of ratification/accession to the BTWC:  
 National point of contact :  
    
